Skip to Content

Latest Articles

Bigger Upside than the FAANGs

Jul 25, 2018

For five years now, investors have been in love with a handful of giant technology stocks. You can call them the Four Horsemen of technology – or make that five or six depending on which names you include. You can also call them by some version of the acronym they have come to be known by. Whatever you call them, these stocks have been and continue to be powerhouses in terms of growth and performance. In fact, stocks in the most common grouping – FAANG – now make up more than 10% of the S&P 500. Continue Reading…

Buy TSG to Ride the Sports Betting Trend

Jul 22, 2018

As a lover of both sports and investing, I have been following gambling and sports-related stocks for years. I knew (or at least hoped) that one day the federal ban would be abolished, so I already had a long watch list of companies that would benefit from such a scenario. Well, that hunch is finally paying off as the monumental decision by the Supreme Court to allow states to legalize sports gambling has created a new investment opportunity. That brings me to The Stars Group (TSG), which is the largest online poker company in the world and also boasts one of the fastest growing online casinos and sportsbooks. Continue Reading…

CGC Is at the Epicenter of a Budding Marijuana Industry

Jul 20, 2018

I have always employed a strategy where I first uncover a growing mega-trend and then dive deeper to discover the companies that are leading the way within it. I believe this strategy works especially well in the booming legal marijuana industry, which is why I have placed my bet on Canopy Growth (CGC). Based in Canada, CGC is currently the largest marijuana company in the world with a market capitalization of $5.8 billion. Its growth over the years has been both organic and the result of acquisitions. This company is in prime position to capture a large portion of the Canadian recreational marijuana market once sales begin October. Continue Reading…

Making a Fortune in the Sports Betting Boom

Jul 18, 2018

It’s one thing to bet on who you think might win a big sporting event like the World Cup. It’s another thing to bet on which players will score goals…and to do it legally…and in the U.S.! Yet, that’s exactly what happened this past Sunday as France met Croatia in the World Cup final. According to a story on nj.com, Monmouth Park was filled to capacity by the time the match was set to start at 11 a.m. ET. More than 500 people were crammed into the sports bar and sports betting area. Beyond betting on the outcome of the game, there are now so-called proposition bets on things like whether the game would be won in regulation or overtime, how many corner kicks there would be and more. Continue Reading…

TDOC is the Future of Healthcare

Jul 15, 2018

When betting on an industry of the future, it’s typically a good idea to invest in the leader of that space. That’s the strategy I’m taking when it comes to healthcare. There is no question that this sector is changing for the better, and one of the trends that’s leading the way is telehealth. In lieu of spending an entire day sitting in the waiting room of a doctor’s office when all you have is a cold, you can now check in with a medical professional from the comfort of your own home. That’s where Teladoc (TDOC) comes in. The company was founded in 2002 with a goal of tackling healthcare’s three biggest issues – access, cost and quality. Continue Reading…

The Secrets of Getting Rich in Speculative Stocks

Jul 13, 2018

Over the past few days, I’ve described a unique investment technique that if performed right just once, can allow you to never worry about money again. I’m talking about venture capital-style investing. As I’ve covered, venture capitalists are the grand slam home run hitters of the investment world. They back small companies in their early stages. When it comes to evaluating early-stage companies, I use a “five factor” analytical model. In my experience, the biggest early-stage stock winners tend to have five key qualities that define their businesses. Continue Reading…

Buy TCEHY on Overblown Trade War Fears

Jul 13, 2018

There is no question as to what headline will drive the summer trading volatility this year – the potential for a trade war between the United States and China. This has been the lead story since the calendar flipped to June, as tweets and off-hour remarks from President Trump have led to increased gyrations and some sizable one-day sell-offs. The hardest hit names have been those with even the slightest ties to China. The broad-based weakness has affected a whole basket of stocks, and because I believe that this trade war will likely never develop, it’s creating a lot of opportunity to buy the dips. Continue Reading…

How to Be Right Less Than 50% of the Time and Get Rich in Stocks

Jul 12, 2018

What would you do with an extra million dollars in cash? Retire tomorrow? Buy a new house? Buy a Ferrari? Put it in the bank and massively increase your financial freedom? Sure, it’s nice to daydream about having an extra million dollars in the bank. But I’m asking you this question because it’s a real-life situation the financial backers of early-stage companies – venture capitalists – often find themselves in. When it comes to extreme wealth creation, few endeavors can compare to being an owner of a small company that grows large. Continue Reading…

How You Can Turn $1,000 into $1,000,000 in the Stock Market

Jul 11, 2018

What were you doing in 1992? The Soviet Union had just collapsed. Bill Clinton defeated George Bush in the presidential election. Roseanne, Home Improvement, and Cheers were huge TV shows. The roaring ‘90s were just getting started. And a new technology called the “Internet” was being introduced to America. Now imagine that around that time, you truly understood how this new technology would change the world. Imagine you could see the major new industries that would fan off the Internet’s creation in a dozen different directions, like spokes on a wheel. Continue Reading…

Buy the Dip in BLUE

Jul 07, 2018

The action in bluebird bio (BLUE) over the last month has been manic to say the least. At first the trading was positive, as the stock rallied to a three-month high in mid-June on the back of impressive results from a Phase I/II study of a drug that treats a blood disease called beta-thalassemia. But by the end of the month BLUE had given back those gains and then some. One of the biggest culprits was Global Blood Therapeutics’ (GBT) announcement that it had received positive data from a Phase III drug trial of a treatment for sickle cell anemia. This blood disease has been a large focus of many biotechs in recent years. Continue Reading…
Don't miss out on the incredible megatrends that are shaping today's market. Gain access to the most powerful market insights and stock advice from Matt McCall absolutely FREE. Join Today!
https://orders.investorplace.com/?cid=MKT450270&eid=MKT473285&encryptedSnaid=&snaid=&step=start